Table 2.
n | Mean±SD | Median (min–max) | n (%) | |
Baseline | ||||
Age | 11 | 49.09±17.78 | 50 (28–81) | |
Duration (months) | 11 | 54.09±54.94 | 57 (1–204) | |
Visual acuity | 11 | 0.61±0.59 | 0.2 (0–1.4) | |
Cell | 11 | 0.73±1.13 | 0.5 (0–4) | |
KPs | ||||
No | 1 (9.10) | |||
Yes | 10 (90.9) | |||
IOP | 11 | 26.73±10.42 | 28 (14-44) | |
Antiglaucoma drug | 11 | 3.00±1.67 | 3 (0–6) | |
Steroid | 11 | 5.45±4.20 | 4 (2–16) |
IOP, intraocular pressure; KP, keratic precipitate.